Nature Communications (Mar 2023)
Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma
Abstract
Genomic instability occurs infrequently in in diffuse large B cell lymphoma (DLBCL), suggesting a therapeutic vulnerability. Here, the authors identify a synergistic combination between the induction of polyploidy by a PLK4 inhibitor and a BCL-2 inhibitor in DLBCL.